Workflow
Therapies for treating cystic fibrosis
icon
Search documents
Bernstein Names Vertex (VRTX) a “Top Biotech Pick” for 2026 Following Upgrade to Outperform
Yahoo Finance· 2026-01-19 12:49
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best future stocks to buy for the long term. On January 12, Bernstein analyst William Pickering upgraded Vertex Pharmaceuticals to Outperform from Market Perform. As this sentiment was announced, Bernstein also officially named Vertex a top biotech pick for 2026. Pickering noted that the biotech sector entered 2026 following an impressive comeback after a three-year downturn. This recovery was highlighted by a 36% gain in 2025, which the fir ...